News
MONDAY, July 7, 2025 — Two babies in Oregon got sick with lead poisoning after eating baby food from Target that was ...
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...
The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical ...
Synthetic products posing as kratom mislead and endanger consumers; AKA urges FDA to take decisive action against violative ...
A federal judge has ruled that recent mass layoffs at the US Department of Health and Human Services were likely unlawful and ...
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary swelling disorder, sending its shares up 33.3% in premarket trading.
ImmunityBio, Inc. (NASDAQ:IBRX) is a clinical-stage immunotherapy company that develops next-generation therapies to treat ...
1h
Stocktwits on MSNKalVista Stock Soars Pre-Market On FDA Approval For Drug In Treating Swelling Disorder: Retail’s ElatedKalVista Pharmaceuticals, Inc. (KALV) on Monday said that the U.S. Food and Drug Administration (FDA) has approved its drug ...
Americans are increasingly demanding that chemicals and toxic food dyes be removed from items they consume, clean with, wear, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results